Area of research
Oncology · Immunology
Research interest
Research interests include CAR-T cell therapy research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, and Glycosylation and Glycoproteins Research.
Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy study
Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors
TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer
O-linked mucin-type glycosylation regulates the transcriptional programme downstream of EGFR
A phase I trial of T4 CAR T-cell immunotherapy in head and neck squamous cancer (HNSCC).
CAR T-cell immunotherapy of MET-expressing malignant mesothelioma
Intracavitary ‘T4 immunotherapy’ of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells
The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9